DIA Europe 2019 has ended

Carol Pitcher-Towner

Alnylam Pharmaceuticals
VP, EU Regulatory Affairs
Carol Pitcher-Towner is Head of International Regulatory Affairs at Alnylam. Alnylam is leading the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of patients who have limited or inadequate treatment options. In her role Carol is responsible for navigating the opportunities and complexities of the CEMEA, Asian and Latam regulatory systems, and for setting innovative and creative global regulatory strategies. Carol has extensive experience in the development and successful registration of innovative products. She attained a first-class honours degree in biochemistry, and completed a PhD and a post-doctoral fellowship before she joined Glaxo Wellcome in 1998.